Altai Protocol Library
1041 protocols and counting
All protocols with references and links
All protocols reviewed by a Medical Oncologist/Hematologist
All protocols in major guidelines included
Ability to create your own protocols
New İndication: Trastuzumab deruxtecan in patients with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after trastuzumab-containing regimen
New İndication: Trastuzumab deruxtecan in patients with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after trastuzumab-containing regimen | |
---|---|
Study: |
|
Efficacy: |
|
Safety: |
|
LANCET Oncol, VOL 24, ISSUE 7, P744-756, JUL 2023 Cutsem Eric Van et al. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study http://doi.org/10.1016/S1470-2045(23)00215-2 Reviewed by Elvin CHALABİYEV, MD on AUG 10, 2023 |
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.